(Q36260702)

13 August 2017

Riboflavin prophylaxis in pediatric and adolescent migraine (English)

1 reference

13 August 2017

1 reference

1 reference

Maria Condò

1

1 reference

13 August 2017

Annio Posar

series ordinal

2

1 reference

13 August 2017

Annalisa Arbizzani

series ordinal

3

1 reference

13 August 2017

Antonia Parmeggiani

series ordinal

4

1 reference

13 August 2017

1 August 2009

1 reference

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

13 August 2017

1 reference

13 August 2017

10

1 reference

13 August 2017

5

1 reference

13 August 2017

361-365

1 reference

https://scigraph.springernature.com/pub.10.1007/s10194-009-0142-2

13 August 2017

0 references

cites work

Complementary and alternative treatments for childhood headaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

The International Classification of Headache Disorders: 2nd edition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Children's ibuprofen suspension for the acute treatment of pediatric migraine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

A quantification of the placebo response in migraine prophylaxis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

31P-magnetic resonance spectroscopy in migraine without aura.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3452096

High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.

29 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0142-2

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0142-2

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0142-2

Melatonin to prevent migraine or tension-type headache in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0142-2

Biliary excretion of riboflavin in man

21 January 2018

1 reference

12 December 2020

NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin

1 reference

12 December 2020

Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency

1 reference

12 December 2020

Riboflavin-responsive complex I deficiency

1 reference

12 December 2020

Levetiracetam prophylaxis in pediatric migraine--an open-label study

1 reference

12 December 2020

10.1007/S10194-009-0142-2

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

19649688

1 reference